Announcement on Shareholding Reduction Plan for Shareholders
Filed with SSE · · 9 pages · Chinese
Sinocelltech Group Limited on 6ix
Earlier from Sinocelltech
- Announcement on Resignation of Deputy General Manager
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCTT11
- Announcement on Voluntary Disclosure of Drug Registration Certificate Obtained by Holding Subsidiary
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Expected Gains in Annual Performance for 2024
Later from Sinocelltech
- Announcement on Realizing Profitability for the 1st Time and Canceling Stock Abbreviation U
- Announcement on Resolution of the 1st Meeting of the 3rd Board of Directors
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Indicative Announcement on Changes in Shareholder's Equity
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1
Follow Sinocelltech into a list and get an email when it puts out news.
Follow Sinocelltech